期刊文献+

单克隆抗体治疗肿瘤的研究进展 被引量:2

Research progress on tumor therapy of the monoclonal antibody
暂未订购
导出
摘要 在过去十年中,单克隆抗体已经实现临床应用并且成为肿瘤治疗的主要药物。抗体能够瞄准和杀死肿瘤细胞,同时通过补体级联或者抗体依赖细胞的细胞毒性激活免疫效应分子最终杀死肿瘤细胞。本文就目前针对肿瘤治疗的单克隆抗体的靶点和临床应用情况做一个综述。 Monoclonal antibody has been the main drug to treat the tumor in the past decade. The antibody can aim at tumor cells,and immune effeetor molecule activated by the C system or the antibody - dependent cytotoxicity kill tumor cells. This article reviewed the current target and clinical application of monoclonal antibody for anti - tumor therapy.
作者 李红玲
机构地区 大丰市中医院
出处 《药学研究》 CAS 2014年第1期44-46,共3页 Journal of Pharmaceutical Research
关键词 单克隆抗体 肿瘤 靶点 Monoclonal antibody Tumour Target
  • 相关文献

参考文献22

  • 1Schreiber RD,Old LJ,Smyth MJ. Cancer immune editing:integrating immunity's roles in cancer suppression and promotion[J].{H}SCIENCE,2011,(6024):1565-1570.
  • 2Reichert J M. Antibodies to watch in 2013 Mid-year update[J].MAbs,2013,(4):513-517.
  • 3Hodi FS,O'Day SJ,McDermott DF. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma[J].{H}New England Journal of Medicine,2010,(8):711-723.
  • 4Gladue RP,Paradis T,Cole SH. The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice[J].{H}Cancer Immunology and Immunotherapy,2011,(7):1009-1017.
  • 5Lewis TS,McCormick RS,Emmerton K. Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma[J].{H}Clinical Cancer Research,2011,(14):4672-4681.
  • 6Rosenblatt J,Glotzbecker B,Mills H. PD-1 blockade by CT-011,anti-PD-1 antibody,enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine[J].{H}Journal of Immunotherapy,2011,(5):409-418.
  • 7Fisher TS,Kamperschroer C,Oliphant T. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity[J].{H}Cancer Immunology lmmunotherapy,2012,(10):1721-1733.
  • 8Simeone E,Ascierto PA. Immunomodulating antibodies in the treatment of metastatic melanoma:the experience with anti-CTLA-4,anti-CD137,and anti-PD1[J].J Immunotoxicol,2012,(3):241-247.
  • 9Trachtman H,Fervenza FC,Gipson DS. A phase 1,single-dose study of fresolimumab,an anti-TGF-β antibody,in treatment-resistant primary focal segmental glomerulosclerosis[J].{H}Kidney International,2011,(11):1236-1243.
  • 10Jürgensmeier JM,Schmoll HJ,Robertson JD. Prognostic and predictive value of VEGF,sVEGFR-2 and CEA in mCRC studies comparing cediranib,bevacizumab and chemotherapy[J].{H}British Journal of Cancer,2013,(6):1316-1323.

同被引文献29

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部